THERMALIN DIABETES, INC.

Address

10000 Cedar Avenue
CLEVELAND, OH, -

Information

DUNS: 802601570
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Enabling implantable artificial pancreas pumps with heat-stable, ultra-rapid insulin

    Amount: $299,991.00

    Project Summary We seek to develop an ultra stable ultra fast insulin analog formulation for use in advanced smart pumps in the treatment of diabetes mellitus A commercially available insulin form ...

    SBIRPhase I2016Department of Health and Human Services
  2. Optimizing diabetes therapy: re-engineering insulin as a biased agonist

    Amount: $249,993.00

    DESCRIPTION provided by applicant Insulin is essential to the treatment of Type diabetes mellitus DM and is often required for optimal management of Type DM Despite its many decades of clini ...

    SBIRPhase I2015Department of Health and Human Services
  3. An Ultra-Stable Insulin Analog with Intrinsic Basal-Bolus Action

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Pre-mixed formulations of soluble prandial insulin analogs and NPH micro-crystalline suspensions provide a simplified and cost-effective basal-bolus regimen for pa ...

    SBIRPhase I2014Department of Health and Human Services
  4. Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation

    Amount: $1,496,342.00

    DESCRIPTION provided by applicant In this Phase SBIR application we seek to advance toward human clinical trials a rapid acting and ultra concentrated monomeric insulin analog of novel halogen b ...

    SBIRPhase II2014Department of Health and Human Services
  5. A Promotora Program to Prevent Primary Tooth Decay in Low-income Latino Children

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): We seek to develop a rapid-acting U-500 insulin analog formulation for patients with Type 2 and Type 1 diabetes mellitus (T2DM and T1DM). Such a novel product woul ...

    SBIRPhase I2013Department of Health and Human Services
  6. Smart Capsule for Automatic Adherence Monitoring

    Amount: $299,976.00

    DESCRIPTION (provided by applicant): Close-loop systems of insulin delivery-comprising an insulin pump, continuous glucose monitor, and feedback-based control algorithm-provide a promising technology ...

    SBIRPhase I2013Department of Health and Human Services
  7. Chlorolog: Production Scaling and Testing of a Fast-Acting, Ultra-stable Insulin

    Amount: $4,469,515.00

    DESCRIPTION (provided by applicant): We seek to develop a novel insulin analog to enhance the safety and efficacy of insulin pump therapy with broad application to the Artificial Pancreas Project ( s ...

    SBIRPhase II2012Department of Health and Human Services
  8. Manipulating Aromaticity: characterization of an ultra-rapid insulin analog

    Amount: $601,274.00

    DESCRIPTION (provided by applicant): We seek to develop an ultra-fast insulin analog formulation for the treatment of diabetes mellitus. Ultra-fast pharmacokinetic/dynamic (PK/PD) promises to enable s ...

    SBIRPhase I2012Department of Health and Human Services
  9. Optimized Receptor Binding Profile in an Ultra-Stable, Ultra-Rapid-Acting Insulin

    Amount: $622,539.00

    DESCRIPTION (provided by applicant): We seek to develop an ultra-fast, zinc-free insulin analog formulation for the treatment of diabetes mellitus. An ultra-fast pharmacokinetic-dynamic (PK/PD) profil ...

    SBIRPhase I2011Department of Health and Human Services
  10. Halogenated Insulin: a fast-acting, ultra stable analog.

    Amount: $392,091.00

    DESCRIPTION (provided by applicant): A Phase 1 SBIR program of pre-clinical development is proposed focusing on a novel rapid-acting insulin analog for the treatment of diabetes mellitus. Designated I ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government